A client is taking the inhaled anticholinergic medication,
ipratropium. Provide one (1) adverse effect associated with this
medication, and two (2) points important to discuss with the client
about this medication.
Suggested Pharmacology Learning Activity: Anti-inflammatory
Meds – Bronchodilators
CNS: dizziness, headache, nervousness.
EENT: blurred vision, sore throatnasal only: epistaxis, nasal
dryness/irritation
Resp: bronchospasm, cough
CV: hypotension, palpitations
GI: GI irritation, nausea
Derm: rash
Misc: allergic reactions
Instruct patient in proper use of inhaler, nebulizer, or nasal
spray and to take medication as directed. Take missed doses as
soon as remembered unless almost time for the next dose; space
remaining doses evenly during day. Do not double doses.
Advise patient that rinsing mouth after using inhaler, good
oral hygiene, and sugarless gum or candy may minimize
dry mouth. Health care professional should be notified if
stomatitis occurs or if dry mouth persists for more than 2
wk.
Inhalation: Caution patient not to exceed 12 doses within 24
hr. Patient should notify health care professional if symptoms do
not improve within 30 min after administration of medication or
if condition worsens.
Explain need for pulmonary function tests prior to and
periodically during therapy to determine effectiveness of
medication.
Caution patient to avoid spraying medication in eyes; may
cause blurring of vision or irritation.
Advise patient to inform health care professional if cough,
nervousness, headache, dizziness, nausea, or GI distress
This study source was downloaded by 100000858936669 from CourseHero.com on 01-12-2023 12:05:30 GMT -06:00
https://www.coursehero.com/file/64456941/VATI-pharm-remidiationdocx/
ipratropium. Provide one (1) adverse effect associated with this
medication, and two (2) points important to discuss with the client
about this medication.
Suggested Pharmacology Learning Activity: Anti-inflammatory
Meds – Bronchodilators
CNS: dizziness, headache, nervousness.
EENT: blurred vision, sore throatnasal only: epistaxis, nasal
dryness/irritation
Resp: bronchospasm, cough
CV: hypotension, palpitations
GI: GI irritation, nausea
Derm: rash
Misc: allergic reactions
Instruct patient in proper use of inhaler, nebulizer, or nasal
spray and to take medication as directed. Take missed doses as
soon as remembered unless almost time for the next dose; space
remaining doses evenly during day. Do not double doses.
Advise patient that rinsing mouth after using inhaler, good
oral hygiene, and sugarless gum or candy may minimize
dry mouth. Health care professional should be notified if
stomatitis occurs or if dry mouth persists for more than 2
wk.
Inhalation: Caution patient not to exceed 12 doses within 24
hr. Patient should notify health care professional if symptoms do
not improve within 30 min after administration of medication or
if condition worsens.
Explain need for pulmonary function tests prior to and
periodically during therapy to determine effectiveness of
medication.
Caution patient to avoid spraying medication in eyes; may
cause blurring of vision or irritation.
Advise patient to inform health care professional if cough,
nervousness, headache, dizziness, nausea, or GI distress
This study source was downloaded by 100000858936669 from CourseHero.com on 01-12-2023 12:05:30 GMT -06:00
https://www.coursehero.com/file/64456941/VATI-pharm-remidiationdocx/
